5 Best Stocks For Day Trading

2. Gracell Biotechnologies Inc. (NASDAQ:GRCL)

One Week Volatility: 19.58%

Number of Hedge Fund Investors In Q2 2023: 11

Gracell Biotechnologies Inc. (NASDAQ:GRCL) is another biotechnology company but one that is headquartered in China. It develops cancer treatments, and the firm started dosing patients for a cancer drug trial in the U.S. in September 2023.

Insider Monkey scanned 910 hedge fund portfolios for their shareholdings during this year’s June quarter and found that 11 had held a stake in the company. Gracell Biotechnologies Inc. (NASDAQ:GRCL)’s biggest hedge fund stakeholder is Samuel Isaly’s OrbiMed Advisors through a stake worth $34.4 million.

Follow Gracell Biotechnologies Inc.